Analysis of telomere status in patients with Fanconi anaemia (FA) has previously been carried out by measurement of telomere restriction fragment (TRF) length by Southern blotting and densitometry. Results from these studies indicated that FA patients had significant reduction in telomere length compared with age-matched controls. This paper confirms and extends these findings using a direct FISH technique, which showed that 15 out of 16 FA patients had increased loss of telomere signals compared with controls. In 12 out of the 16 patients, decrease in telomere signal intensity could also be detected using a Q-FISH approach.   

1.
Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JCW, Gordon-Smith EC: Progressive telomere shortening in aplastic anaemia. Blood 91:3582–3592 (1998).
2.
Barber JCK, Reed CJ, Dahoun SP, Joyce CA: Amplification of a pseudogene cassette underlies euchromatic variation of 16p at the cytogenetic level. Hum Genet 10:211–218 (1999).
3.
Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25–34 (1997).
4.
Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866–868 (1990).
5.
Heinrich MC, Hoatlin ME, Zigler AJ, Silvey KV, Bakke AC, Keeble WW, Zhi Y, Reifsteck CA, Grompe M, Brown MG, Magenis RE, Olson SB, Bagby GC: DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood 91:275–287 (1998).
6.
Henderson S, Allsopp R, Spector D, Wang S, Harley C: In situ analysis of changes in telomere size during replicative ageing and cell transformation. J Cell Biology 134:1–12 (1996).
7.
Hultdin M, Gronlund E, Norrback KF, Eriksson-Lindstrom E, Just T, Roos G: Telomere analysis by fluorescence in situ hybridisation and flow cytometry. Nucl Acids Res 26:3651–3656 (1998).
8.
Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Yahata N, Ando K, Toyama K, Hoshika A, Takasaki M, Mori M, Shay JW: Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet 102:397–402 (1998).
9.
Kennedy AW, Hart WP: Multiple squamous cell carcinomas in Fanconi’s Anaemia. Cancer 50:811–814 (1982).
10.
Lansdorp PM, Verwoerd NP, Van de Rijke FM, Dragosaka V, Little M, Dirks RE, Raap AK, Tanke HJ: Heterogeneity in telomere length of human chromosomes. Hum molec Genet 5:685–691 (1996).
11.
Leteurtre F, Li X, Guardiola P, Le Roux G, Sergere JC, Richard P, Carosella ED, Gluckman E: Accelerated telomere shortening and telomerase activation in Fanconi’s Anaemia. Br J Haematol 105:883–893 (1999).
12.
Reed K, Ravikumar TS, Gifford RR, Grage TB: The association of Fanconi’s anaemia and squamous cell carcinoma. Cancer 52:926–928 (1983).
13.
Zijlmans JM, Martens UM, Poon SS, Raap AK, Tanke HJ, Ward RK, Lansdorp PM: Telomeres in the mouse have large inter-chromosomal variations in the number of TTAGGG repeats. Proc natl Acad Sci, USA 94:7423–7428 (1997).
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.